Identifying cancer in dense breast tissue

Discovering genes in mammary cancer by insertional mutagenesis

Novel bi-specific TCR-based reagents for targeted cancer immunotherapy

Centrosomes in ovarian cancer

Hallmarks of cancer cell development

Nivolumab and ipilimumab combination for advanced skin cancer

Long-term clinical outcomes and analyses of atezolizumab for mTNBC

Checkmate 067 - combined nivolumab and ipilimumab

IDH metabolites induce a BRCAness that can be exploited by PARP inhibitors

Durable responses to avelumab in patients with Merkel cell carcinoma

Atezolizumab in metastatic TNBC: Long-term clinical outcomes and biomarker analyses

Five-year follow-up of nivolumab in NSCLC